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Abstract: Dengue virus (DENV) is an arthropod-borne virus (arbovirus) transmitted by the Aedes
mosquitoes, mainly Aedes aegypti. Dengue fever is a rapidly growing disease with expanding
geographical distribution worldwide. We investigated a high number of non-malaria febrile cases
reported to health clinics in refugee camps in the five states of Darfur between August 2015 and
March 2016. The clinical presentation of cases and case definition criteria suggested involvement of
one or more arboviral hemorrhagic fevers. Out of 560 suspected cases, we collected and analyzed 204
blood samples and serologically positive samples were confirmed by PCR. We identified 32 (15.7%)
dengue viral infections, six West Nile virus infections, and three Crimean–Congo viral infections.
Dengue infections were found in four out of the five Darfur states. We reported the first dengue fever
outbreak in the Darfur region. Our results highlight the need for public health education and further
molecular, phylogenetic, and entomological investigations for a better understanding of the disease
transmission and the associated risk factors in the region.
Keywords: dengue; outbreak; emergence; West Nile virus (WNV); hemorrhagic fever; Crimean–
Congo hemorrhagic fever (CCHF); epidemic; Aedes aegypti; Greater Darfur; Sudan
1. Introduction
Dengue fever (DF) is a mosquito-borne viral disease caused by one of four closely-related dengue
virus serotypes (DENV1–4) of the genus Flavivirus and family Flaviviridae and it is mainly transmitted
by Aedes aegypti with other species of Aedes mosquito involved [1,2]. Dengue infection has different
clinical presentations ranged from a self-limiting flu-like illness to the fatal severe form of dengue
hemorrhagic fever or dengue shock syndrome [1,3]. Dengue is a rapidly expanding arboviral infection
currently present in at least 128 countries with an estimated 390 million dengue infections annually
and 3.97 billion people at risk of infection [4–6].
Dengue virus transmission is influenced by several factors, including climate change [7], the
global trade, human population dynamics, and international travel, that facilitate the spread of the
vectors and introduction of the DENV into new areas [8–12]. Unplanned urbanization and high human
population density play a major role in the DENV transmission and outbreaks [13–15].
DF is a global public health problem with common epidemics in the tropical countries. DF
incidences are greatly underestimated because most dengue infections are self-limiting, inapparent
cases that usually go unreported [3,4]. The unnoticeable, persistent transmission of the dengue virus
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usually results in the emergence of epidemics of different scales which are mainly influenced by the
human population density, susceptibility, and previous exposure to DENV and the density of the
mosquito vectors [1,16,17]. In addition, armed conflicts and living in a humanitarian setting renders
communities more vulnerable to infectious diseases, including DF [18].
In Sudan, DF is considered a major public health issue in the eastern region of the country,
where it has been reported since 1908 [19], with endemicity and frequent outbreaks in the coastal
and sub-coastal areas of the Red Sea and Kassala states [20–24]. Yellow fever and Crimean–Congo
hemorrhagic fever are endemic in Darfur and the area has recently suffered from one of the worst
yellow fever epidemics worldwide [25–27]. The outbreak of yellow fever was influenced by the living
condition in a humanitarian setting that favored the establishment of Ae. aegypti, the same main vector
of DF [1,18]. In this communication, we report the first outbreak of dengue and dengue hemorrhagic
fever along with West Nile virus and Crimean–Congo hemorhagic fever infections in the greater Darfur
region, Western Sudan.
2. Materials and Methods
2.1. Study Area
This health facility-based cross-sectional study was conducted in 29 health facilities, mainly in
refugee camps throughout Darfur region. Darfur is a vast region of 5 federal states located in western
Sudan, along the borders with Libya, Chad, Central African Republic, and South Sudan (Figure 1),
with a total area of 493,180 km2 and population of 9,241,369 individuals. It is located between 14.3783◦
N, 24.9042◦ E and in mainly desert and semi-arid area. Since 2003, the area has been affected by an
armed conflict and civil unrest that has led to massive internal displacement and immigration [28].Trop. Med. Infect. Dis. 2019, 4, x FOR PEER REVIEW 3 of 8 
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2.2. The Outbreak Investigation
An unusually high number of cases of non-malaria febrile illness were reported in the region in
August 2015. Following a well-established case definition (Sudan Federal Ministry of Health) based on
the clinical presentation, we identified suspected cases of hemorrhagic fever presenting to the health
clinics of 29 refugee-camps in East, West, South, North, and Central Darfur states (Figure 1) between
August 29 2015 and February 16 2016. Blood samples were collected from patients as soon as they were
identified as a suspected case and tested for the major arboviral infectious agents of dengue fever (DF),
yellow fever (YF), Rift Valley fever (RVF), Crimean–Congo Hemorrhagic Fever (CCHF), West Nile
virus (WNV), chikungunya virus (CHIKV), and Zika virus (ZIKV). Arboviral-specific enzyme-linked
immunosorbent assays (IgM capture ELISA) were performed using commercially available kits and
following manufacturer’s instructions (Panbio, Inverness Medical Innovations Australia Pty Ltd,
Brisbane, Australia). Serologically positive samples were confirmed by using commercially available
Real Time RT-PCR Kits (Shnaghai ZJ Bio-Tech Co.Ltd, Shanghai, China) following manufacturer’s
guidelines. Due to limited blood samples and resources, using blood samples left from previous
analyses, up to 5 DENV positive samples were pooled together for the DENV serotype analysis. All
serological and molecular assays were done at the Sudan National Public Health Laboratory. This
study has been done using clinical samples and data obtained during the outbreak and all personal
identifiers have been excluded.
3. Results
We identified 560 suspected cases of hemorrhagic fever from 29 localities across the five states of
Darfur during the study period and the majority of the cases were from the West Darfur state (Table 1).
The first suspected cases appeared on 29 August 2015 and the last one was reported on 16 February
2016, with the peak of the outbreak in November (Figure 2). The fatality rate among the suspected
cases was 18.2%, but only one confirmed case of dengue died. The clinical presentation of the dengue
infections was generally severe, with all cases presenting with fever. The majority presented with
bleeding and headache and less than half of cases with joint pain and anorexia (Figure 3). Nearly
two-thirds of the suspected cases refused to donate blood samples (Table 1).
Molecular analysis confirmed 32 positive cases of dengue fever out of the 204 (15.7%) from
11 localities in the Darfur area with 24 (75%) cases from the West Darfur state. Six (2.9%) cases of
West Nile virus (WNV) were detected in samples from the states of West and North Darfur and three
(1.5%) cases of Crimean–Congo hemorrhagic fever (CCHF) were identified in East Darfur (Table 1). No
cases of Zika virus (ZIKV), yellow fever (YF), chikungunya virus (CHIKV), or Rift Valley fever (RVF)
were detected (Table 1). Most of the dengue infections (72%) were in children and young adults under
25 years old, while all CCHF cases were adults (Table 2). We found no association between infection
and gender. Limited serotype analysis of DENV serotypes revealed that both DENV-1 and DENV-3
exist in the area.
Table 1. Number of hemorrhagic fever suspected cases, ratio of blood samples obtained and lab results
per state of Greater Darfur from 29 August 2015 to 16 February 2016.
State SuspectedCases
Samples Collected
(Percentage) DENV WNV CCHFV Negative
Central Darfur 74 55 (74%) 5 0 0 50
East Darfur 26 22 (85%) 0 0 3 19
North Darfur 128 27 (21%) 1 1 0 25
South Darfur 20 15 (75%) 2 0 0 13
West Darfur 312 85 (27%) 24 5 0 56
Total 560 204 (36%) 32 6 3 163
DENV: dengue virus; WNV: West Nile virus; CCHFV: Crimean–Congo hemorrhagic fever virus.
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Figure 2. Epidemic curve of the first dengue fever outbreak in Greater Darfur showing the development
of the outbreak and case fatality from August 2015 to February 2016. Number of DF confirmed cases
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before the development of a detectable immune response (antibodies). The protocol of the Sudan 
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Table 2. Age and sex ratio of confirmed arboviral infections.
Age Group DF WNV CCHF F:M
0–10 years 12 0 0 1:2
11–25 years 11 5 0 1.3:1
26–45 years 8 1 3 1:1
Elder than 46 years 1 0 0 1:0
Total 32 6 3 -
DF: dengue fever; WNV: West Nile virus; CCHFV: Crimean–Congo hemorrhagic fever. F:M = Female to Male ratio.
4. Discussion
In this communication, we investigated the first outbreak of dengue fever in the Darfur area
and we confirmed the presence of DENV in all states of Darfur, except East Darfur. We believe the
prevalence of dengue fever cases might be higher than reported here because of the passive nature of
our survey and reliance on patients’ presentation at the health facilities, imbalance in the blood sample
donation between areas, and the refusal rate for blood donation. The DENV might be present in East
Darfur, but we failed to detect it because most DENV infections are mild or asymptomatic [3]. The
majority (75%) of the detected DENV infections presented with bleeding, suggesting the involvement
of dengue hemorrhagic fever, one of the severe forms of the disease according to the guidelines of the
World Health Organization [2]. Dengue fever in Sudan has been localized to eastern Sudan [20,21,24],
with frequent epidemics in the area since the early 1900s [19,23,27]. Darfur has a recent history of
yellow fever epidemics [25,29], but DENV has only been detected in a few cases in AlFashir, the capital
city of North Darfur, for the first time in 2014.
Compared to dengue fever, similarly high infections of yellow fever among children and young
adults have recently been reported in the same area. Both arboviral infections are transmitted by the
same mosquito vector, Ae. aegypti, suggesting similarity in the behavior of either human, vector, or
both [29]. More detailed studies are needed to be address the role of the mosquito vector of arboviruses
in Darfur. Unlike previous studies of arboviral outbreaks in the area, we did not notice any association
between infection and gender [29].
The severe clinical presentations of dengue fever cases during this outbreak seems to suggest
a lack of previous exposure, but it could also be attributed to the co-circulation of two serotypes of
dengue virus 1 and 3, since a secondary infection with a different serotype of the virus is a risk factor
for developing severe disease [1]. Our limited serotype analysis showed both DENV-1 and -3 in the
area and did not exclude others, even though DENV-2 has been recently identified in Kassala state, East
Sudan [30]. In addition, our serotype analysis did not address the issue of co-infection with multiple
serotypes. The notably high negative results could be due to collection of the blood samples before the
development of a detectable immune response (antibodies). The protocol of the Sudan National Public
Health Laboratory is to use serological tests to screen the blood samples for infections, followed by
using RT-PCR assays to confirm the serologically positive cases [31]. The high mortality rate in the
first weeks of the outbreak might be attributed to the start of treatment before confirmation of DENV
infection. Most of these cases were treated as severe malaria cases, which is a common confusion in
resource-limited settings [25].
Greater Darfur has suffered civil war and massive population displacement that led most people
to live in very populated refugee camps with limited basic services [18]. Such conditions increased
the vulnerability of the population to the risk of infectious diseases, including dengue fever and
other arboviral infections, and made the health system very fragile. The arrival of the UNAMID
(The African Union—United Nations Hybrid Operation in Darfur) peacekeeping force to Darfur is a
possible scenario for the introduction of the DENV into the area, as some of those troops are coming
from dengue fever endemic areas [18,27]. Another possible scenario for introducing DENV into the
area is through immigrants from neighboring countries with endemic dengue fever, who came to
work in the local gold mines [28]. Later entomological surveys showed Ae. aegypti to be the dominant
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mosquito in the area, with an incidence of up to 86% in manmade water containers (unpublished data),
which refugees use to store water. This created typical breeding sites for the Ae. aegypti mosquito. This
situation has most likely contributed to the epidemic of yellow fever in the same area in 2012 [8,29,31].
One of the limitations of this study is the refusal of blood sample donation for diagnosis that has
affected our sample size. Such refusal has been noted previously in the area [31] and requires public
health campaigns to educate the local population about these infectious agents and encourage health
care seeking behavioral change. Another limitation was our inability to run a full serotype analysis
of DENV and investigating the co-infection possibility. In addition, this survey has been based on
passive surveillance and only detected severe cases from healthcare centers. Further entomological,
molecular, and phylogenetic investigations are urgently needed to improve our understanding of the
risk factors influencing the emergence and outbreaks of dengue fever in the area. Furthermore, we
highlight the need to improve the health and living conditions of people in refugee camps and the
need for preventive measures against new and endemic arboviral diseases.
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